Back to search
FDAFDA · Food and drugs·Recall number D-0040-2025

Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317

Published November 13, 2024 · Recall initiated: September 30, 2024

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Presence of glass particulates.

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
Staska Pharmaceuticals, Inc.
Distributor
Nationwide in the USA
Lot
Lot #SP2400058, Exp 12/31/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card